Firefly Neuroscience, Inc.
AIFF- Exchange
- Nasdaq
- Industry
- Services-Prepackaged Software
- SEC CIK
- 0000803578
No open-market purchases or sales by Firefly Neuroscience, Inc. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $1.96M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Firefly Neuroscience, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 0 | 9 | +9 |
| Shares | 0 | 225.2K | +225.2K |
| Value | $0 | $1.11M | +$1.11M |
New holders (9)
Institutions that held Firefly Neuroscience, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Lafayette Investments, Inc. | 124,797 | $618.0K | 0.15% |
| Renaissance Technologies LLC | 37,800 | $187.0K | 0.00% |
| Moors & Cabot, Inc. | 17,988 | $89.0K | 0.01% |
| Virtu Financial LLC | 11,993 | $59.0K | 0.01% |
| United Capital Financial Advisers, LLC | 10,000 | $50.0K | 0.00% |
| WMS Partners, LLC | 10,000 | $50.0K | 0.01% |
| Advisor Group Holdings, Inc. | 8,400 | $42.0K | 0.00% |
| Morgan Stanley | 3,519 | $17.0K | 0.00% |
| UBS Group AG | 653 | $3.00K | 0.00% |
Sold out (0)
Institutions that held Firefly Neuroscience, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
None.